Related Experiment Video

Updated: Apr 27, 2026

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

6.5K

Opposing effects of target overexpression reveal drug mechanisms

Adam C Palmer1, Roy Kishony2

  • 1Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, Massachusetts 02115, USA.

Nature Communications
|July 2, 2014
PubMed

Insights

Target overexpression in bacteria can increase, decrease, or not change antibiotic resistance. The drug-target interaction mechanism predicts whether target overexpression confers resistance or sensitivity.

Area of Science:

  • Microbiology
  • Biochemistry
  • Evolutionary Biology

Background:

  • Overexpression of drug targets often increases drug resistance, aiding adaptive evolution and target identification.
  • The reasons for variable outcomes of target overexpression on drug resistance remain unclear.
  • Understanding this variability is crucial for predicting drug resistance mechanisms and developing novel therapeutics.

Purpose of the Study:

  • To investigate the diverse effects of antibiotic target overexpression on drug resistance in Escherichia coli.
  • To elucidate the underlying biochemical mechanisms that dictate whether target overexpression leads to resistance or sensitivity.
  • To develop a predictive framework for understanding drug-target interactions and resistance evolution.

Main Methods:

  • Gradual overexpression of antibiotic targets in Escherichia coli.
  • Phenotypic analysis of drug resistance levels under varying target expression.
  • Quantitative modeling of enzyme inhibition, incorporating fitness costs and drug-enzyme complex activity.

Main Results:

  • Antibiotic target overexpression resulted in varied outcomes: increased, unchanged, decreased, or non-monotonic changes in drug resistance.
  • Different inhibitors targeting the same molecule produced opposing effects on resistance.
  • Quantitative models successfully explained these contradicting effects based on drug-target interaction mechanisms and fitness costs.

Conclusions:

  • Drug target overexpression confers resistance or sensitivity predictably based on the drug's mechanism of action.
  • The variable presence of target overexpression as a resistance mechanism in nature is explained by drug-specific properties.
  • While overexpression screens may not identify unknown targets, they offer a systematic method to analyze known targets and differentiate drug action mechanisms.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

6.5K

Related Concept Videos

Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
9.1K
Principles of Drug Action01:24

Principles of Drug Action

Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
9.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
8.3K
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119